Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
United States Health Care
Biopharma Week in Review - October 14, 2024
Thematic (Sector/Industry)
316 Views
14 Oct 2024 15:58
Issuer-paid
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, SRRK gained from muscle-building data in SMA
What is covered in the Full Insight:
Introduction to Biopharma Updates
Clinical Data Highlights
Regulatory Updates
Research Innovations
Market Reactions and M&A Activity
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Loading
Trending Insights
More »
Hygon/Sugon Merger: BIG Index Flows on Completion
Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
Holcim Spin-off (Amrize) Deep Dive
Growth Broadly Back In The Black
HDB Financial IPO: The Investment Case
Top Unpaywalled Insights
More »
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
[IO Technicals 2025/25] Bearish Momentum Strengthens
VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Insight Stream
Biopharma Week in Review - October 14, 2024
14 Oct 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x